JP2011500091A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500091A5
JP2011500091A5 JP2010531283A JP2010531283A JP2011500091A5 JP 2011500091 A5 JP2011500091 A5 JP 2011500091A5 JP 2010531283 A JP2010531283 A JP 2010531283A JP 2010531283 A JP2010531283 A JP 2010531283A JP 2011500091 A5 JP2011500091 A5 JP 2011500091A5
Authority
JP
Japan
Prior art keywords
rate
binding
protein
data
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500091A (ja
JP5808536B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/081175 external-priority patent/WO2009055711A2/en
Publication of JP2011500091A publication Critical patent/JP2011500091A/ja
Publication of JP2011500091A5 publication Critical patent/JP2011500091A5/ja
Application granted granted Critical
Publication of JP5808536B2 publication Critical patent/JP5808536B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531283A 2007-10-25 2008-10-24 抗rsvgタンパク質抗体 Active JP5808536B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46907P 2007-10-25 2007-10-25
US61/000,469 2007-10-25
US8940108P 2008-08-15 2008-08-15
US61/089,401 2008-08-15
PCT/US2008/081175 WO2009055711A2 (en) 2007-10-25 2008-10-24 Anti-rsv g protein antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015006644A Division JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Publications (3)

Publication Number Publication Date
JP2011500091A JP2011500091A (ja) 2011-01-06
JP2011500091A5 true JP2011500091A5 (enExample) 2011-10-27
JP5808536B2 JP5808536B2 (ja) 2015-11-10

Family

ID=40580419

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010531283A Active JP5808536B2 (ja) 2007-10-25 2008-10-24 抗rsvgタンパク質抗体
JP2015006644A Withdrawn JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015006644A Withdrawn JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Country Status (14)

Country Link
US (3) US7736648B2 (enExample)
EP (1) EP2214711B1 (enExample)
JP (2) JP5808536B2 (enExample)
KR (1) KR101671452B1 (enExample)
CN (1) CN101808663B (enExample)
AU (1) AU2008316703B2 (enExample)
BR (1) BRPI0819210A2 (enExample)
CA (1) CA2703667C (enExample)
IL (1) IL205257A (enExample)
MX (1) MX2010004482A (enExample)
NZ (1) NZ585589A (enExample)
RU (1) RU2526517C2 (enExample)
WO (1) WO2009055711A2 (enExample)
ZA (1) ZA201003131B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506749A1 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
MX2010004482A (es) * 2007-10-25 2010-07-06 Trellis Bioscience Inc Anticuerpos anti-proteina g vsr.
WO2013095091A2 (en) 2011-11-17 2013-06-27 Aimm Therapeutics B.V. Rsv g protein specific antibodies
US10131709B2 (en) 2011-12-28 2018-11-20 Immunoqure Ag Nucleic acid molecules encoding monoclonal antibodies specific for IL-22
WO2013098420A1 (en) * 2011-12-28 2013-07-04 Immunoqure Ag Method of isolating human antibodies
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
CN111303278B (zh) * 2013-04-15 2022-09-06 扬森疫苗与预防公司 结合到rsv g蛋白的人类抗体
KR102201555B1 (ko) * 2013-04-15 2021-01-12 얀센 백신스 앤드 프리벤션 비.브이. Rsv g 단백질에 결합하는 인간 항체
JP6412107B2 (ja) * 2013-04-15 2018-10-24 ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. Rsvgタンパク質に結合するヒト抗体
AU2015213593B2 (en) 2014-02-10 2020-09-03 Igm Biosciences, Inc. IgA multi-specific binding molecules
CN103911389A (zh) * 2014-04-09 2014-07-09 南昌大学 一种检测人呼吸道合胞病毒抗体的g和f蛋白的制备方法
PT3227339T (pt) 2014-12-05 2022-01-14 Eureka Therapeutics Inc Recetores de antigénio quiméricos que têm como alvo o recetor 4 acoplado a proteína g e utilizações dos mesmos
KR20230159637A (ko) 2014-12-05 2023-11-21 메모리얼 슬로안 케터링 캔서 센터 G-단백질 커플화 수용체를 표적화하는 항체 및 이의 사용 방법
CN106496324B (zh) * 2015-11-30 2020-01-14 天津昊免生物技术有限公司 一种抗呼吸道合胞病毒的全人源抗体
CN105542003B (zh) * 2016-03-01 2019-12-06 苏州博泰神州生物技术有限公司 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
PE20191404A1 (es) 2017-01-27 2019-10-04 Ngm Biopharmaceuticals Inc Proteinas de union al receptor de glucagon y metodos para usarlas
US11773143B2 (en) * 2017-10-13 2023-10-03 Trellis Bioscience, Llc Conformational epitopes in respiratory syncytial virus G protein central conserved region
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
US10961315B2 (en) 2018-07-27 2021-03-30 Ngm Biopharmaceuticals, Inc. Method of treating type I diabetes by administering a combination of a glucagon receptor antagonist and an anti-CD3 antibody
WO2020033742A1 (en) * 2018-08-08 2020-02-13 Trellis Bioscience, Llc Improved rsv passive and active vaccines
WO2020175660A1 (ja) 2019-02-28 2020-09-03 Kmバイオロジクス株式会社 Rsv f/gキメラワクチン
WO2021046413A1 (en) 2019-09-06 2021-03-11 Silgan White Cap LLC Tethered, hinged closure
EP4031171A1 (en) * 2019-09-20 2022-07-27 Universiteit Antwerpen A novel human respiratory syncytial virus strain and its use
CN115335399A (zh) 2019-12-06 2022-11-11 朱诺治疗学股份有限公司 针对gprc5d靶结合结构域的抗独特型抗体以及相关组合物和方法
EP4429966A4 (en) 2021-11-08 2026-01-14 Silgan White Cap LLC PROJECTION ON THE NECK OF A CONTAINER
JP2025527263A (ja) * 2022-08-02 2025-08-20 ノナ・バイオサイエンシズ(スーチョウ)カンパニー,リミテッド Msln抗体-薬物コンジュゲート
WO2025106427A1 (en) * 2023-11-14 2025-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing and protective monoclonal antibodies against respiratory syncytial virus (rsv)
WO2025194126A1 (en) * 2024-03-15 2025-09-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Respiratory syncytial virus (rsv) g and f antibodies with high rsv-neutralizing potency

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426077T3 (de) * 1993-05-25 2004-09-02 Wyeth Holdings Corp. Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
US6642062B2 (en) 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US7083950B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. High affinity fusion proteins and therapeutic and diagnostic methods for use
WO2000043040A1 (en) 1999-01-22 2000-07-27 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
AU2002224416A1 (en) 2000-10-18 2002-04-29 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Compositions and methods for modulating RSV infection and immunity
US7413868B2 (en) 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
JP4736037B2 (ja) * 2005-10-26 2011-07-27 株式会社イーベック ヒトgm−csfに結合するヒトのモノクローナル抗体並びにその抗原結合部分
CN1986569A (zh) * 2005-12-23 2007-06-27 首都儿科研究所 人源抗呼吸道合胞病毒中和性基因工程Fab抗体
JPWO2007094423A1 (ja) 2006-02-15 2009-07-09 株式会社イーベック ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分
CA2638833A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
EP2041570A4 (en) 2006-07-12 2010-02-24 Trellis Bioscience Inc CellSpotTM APPLICATIONS
MX2010004482A (es) * 2007-10-25 2010-07-06 Trellis Bioscience Inc Anticuerpos anti-proteina g vsr.

Similar Documents

Publication Publication Date Title
JP2011500091A5 (enExample)
JP2012107017A5 (enExample)
JP2018023398A5 (enExample)
HRP20230844T1 (hr) Anti-cd3 antitijela, bispecifične molekule koje vežu antigen koji veže cd3 i cd20, i njihove upotrebe
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
JP2014527802A5 (enExample)
JP2014518883A5 (enExample)
JP2012143232A5 (enExample)
JP2010521147A5 (enExample)
JP2018536393A5 (enExample)
JP2014061000A5 (enExample)
RU2011143905A (ru) ПОЛИСПЕЦИФИЧНЫЕ АНТИТЕЛА, ВКЛЮЧАЮЩИЕ АНТИТЕЛА ПОЛНОЙ ДЛИНЫ И ОДНОЦЕПОЧЕЧНЫЕ ФРАГМЕНТЫ Fab
JP2015535828A5 (enExample)
JP2015212284A5 (enExample)
RU2015155552A (ru) Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника
JP2013539361A5 (enExample)
JP2013506428A5 (enExample)
JP2013506140A5 (enExample)
EA201390278A1 (ru) Антитела к ох40 и способы их применения
WO2014134561A3 (en) Quantification of vaccine compositions
JP2013524774A5 (enExample)
JP2020516603A5 (enExample)
JP2017510627A5 (enExample)
JP2011237442A5 (enExample)
JP2013535190A5 (enExample)